NIH/NIDDK — Deadline: October 6, 2026
Supports research on multimodal digital health technology for remote management of type 2 diabetes. This funding opportunity invites applications examining the efficacy and clinical effectiveness of multimodality digital health technology approaches to remote diabetes management. Grants
Breakthrough T1D — Deadline: July 2, 2026 (next cycle likely similar timing in 2027)
Supports early-career clinical investigators pursuing patient-oriented type 1 diabetes research, with $1,000,000 available over a five-year project period for clinicians within five years of their first faculty appointment. Keck School of Medicine of USC
ADA Postdoctoral Fellowships
ADA — Deadline: April 30, 2026 (next cycle expected similar timing)
Provides up to three years of funding support including salary stipend, fringe benefit costs, and a training allowance for each award year. Pedsresearch
ADA — Deadline: May 19, 2026 (next cycle expected similar timing)
The Initiator Award supports the transition of scientists from mentored training to independent research faculty, with Phase 1 providing up to two years of support at $100,000 per year. The Accelerator Award targets early-career investigators establishing independent research programs. Diabetes Professionals
Sponsor: Larry L. Hillblom Foundation (LLHF) – Start-Up Grant
Focus areas: Diabetes or Aging (broadly defined)
Eligible institutions: PI’s lab must be based at a California institution
Award: Up to $120,000/year for up to 3 years (non-renewable; includes up to 10% indirects)
Full details and online application are here: https://llhf.org/programs/startup-grant/
The eWEAR Health Prize @ Stanford U. is a pitch competition with the winning contestant receiving a $50,000 prize. The focus of the competition is Deep Tech at the intersection of the medical/health sector with engineering hardware, materials, robotics, artificial intelligence, blockchain, space technology and other interdisciplinary science and engineering. The pitch competition will be an in-person event on November 8, 2024 on the campus of Stanford University.
Requests for applications are now open for new collaborations with the Environmental Determinants of Islet Autoimmunity (ENDIA) Study Group and leading experts around the world to answer important unknowns about disease mechanisms with the long-term aim of preventing type 1 diabetes (T1D).
Launched in late 2017, the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) is designed to carry out newborn screening in the general population, identify infants at high genetic risk of developing type 1 diabetes, and offer them participation in trials to prevent disease initiation.
The goal of this funding opportunity is to accelerate the development of therapies to prevent, slow, halt or reverse the progression of Type 1 Diabetes (T1D) and/or cure established T1D through the advancement of high-impact research carried out by coordinated, multidisciplinary teams.
Breakthrough T1D — rolling/semi-annual cycles
Offers Innovative Awards up to $200,000 for one year for high-risk, high-reward research, and three-year Postdoctoral Fellowships for early-career scientists entering the T1D field. Atom